Ro 205-2349

DRUG2 trials

Sponsors

Hoffmann-La Roche

Conditions

Diabetes

Phase 2

Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus

CompletedNCT00057317

Hoffmann-La RocheDiabetes

Start: 2001-12-31End: 2003-12-31Updated: 2016-08-24

Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus

CompletedNCT00057304

Hoffmann-La RocheDiabetes

Start: 2003-06-30End: 2004-03-31Updated: 2023-04-28